vTv Therapeutics plans to keep its High Point headquarters despite building sale, clinical setback

The prospect of vTv Therapeutics moving its office was raised after it was revealed Cambrex Corp. bought the building. The company is also ending clinical trials for an Alzheimer's drug it has been developing.